Prospective Grant of Exclusive Patent License

The National Institute of Standards and Technology (``NIST''), U.S. Department of Commerce, is contemplating the grant of an exclusive license in the United States of America, its territories, possessions and commonwealths, to NIST's interest in the invention embodied in U.S. Patent Application No. 62/302,855, titled ``Prostate Cancer Detection Using Western Blot Analysis,'' (NIST Docket No. 16-007) to McJimpsey Biotechnologies, Inc. The grant of the license would be for prostate cancer detection.